In human studies, decreased adiponectin levels in the plasma or AT have been observed in obese individuals [39] and patients with type 2 diabetes [40], which shows an association between adiponectin levels and obesity-related metabolic dysfunction. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.